TY  - GEN
AU  - Segura-Sampedro, Juan José
AU  - Morales-Soriano, Rafael
AU  - Arjona-Sanchez, Alvaro
AU  - Cascales-Campos, Pedro
PY  - 2020
DO  - 10.1186/s12957-020-01853-4
UR  - https://hdl.handle.net/20.500.12105/22856
AB  - Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer. This statement is based on a phase III multicenter,...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Ovarian cancer
KW  - HIPEC
KW  - Chemotherapy
KW  - Cytoreductive surgery
KW  - Carcinomatosis
KW  - Prognosis
KW  - Peritoneal Neoplasms
KW  - Neoplasm Recurrence, Local|Female
KW  - Hyperthermia, Induced
KW  - Ovarian Neoplasms
KW  - Humans
KW  - Survival Rate
KW  - Cytoreduction Surgical Procedures
KW  - Percutaneous Coronary Intervention
TI  - Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease
TY  - letter to the editor
ER  -